Show simple item record

dc.contributor.authorWilliamson, Graham
dc.contributor.authorElliott, A
dc.date.accessioned2018-01-02T11:00:45Z
dc.date.available2018-01-02T11:00:45Z
dc.date.issued2017-11-30
dc.identifier.issn1874-4346
dc.identifier.issn1874-4346
dc.identifier.urihttp://hdl.handle.net/10026.1/10465
dc.description.abstract

Abstract

Background:

Many randomised control trials and systematic reviews have examined the benefits of glucocorticoids for the treatment of croup in children, but they have reported mainly on dexamethasone as an oral treatment for croup. No systematic reviews have examined prednisolone alone.

Aim:

To determine in a systematic review of the literature whether a single dose of oral prednisolone is as effective as a single dose of dexamethasone for reducing croup symptoms in children.

Search Strategy:

A detailed search was conducted on the following databases: CINAHL, MEDLINE EBSCO, MEDLINE, OVID, PubMed, The Cochrane Library, ProQuest, EMBASE, JBI, Sum search, and OpenGrey. Study authors were contacted.

Selection Criteria:

Randomised Controlled Trials, clinical trials or chart reviews which examined children with croup who were treated with prednisolone alone, or when prednisolone was compared to a dexamethasone treatment and the effectiveness of the intervention was objectively measured using croup scores and re-attendance as primary outcomes.

Data Collection and Analysis:

Following PRISMA guidelines for systematic reviews, relevant studies were identified. Scores were graded agreed by two independent reviewers using QualSyst.

Main Results:

Four studies met the inclusion criteria, but were too heterogeneous to combine in statistical meta-analysis. The result suggests that although prednisolone appears as effective as dexamethasone when first given, it is less so for preventing re-presentation. Trial sample sizes were small, making firm conclusions difficult, however, a second dose of prednisolone the following day may be useful. More research including cost-benefit analysis is needed to examine the efficacy of prednisolone compared to dexamethasone

dc.format.extent241-261
dc.format.mediumElectronic-eCollection
dc.languageen
dc.language.isoen
dc.publisherBentham Science Publishers Ltd.
dc.subjectCorticosteroids
dc.subjectCroup
dc.subjectDexamethasone
dc.subjectPrednisolone
dc.subjectQualSyst
dc.subjectSystematic review
dc.titleA systematic Review and Comprehensive Critical Analysis Examining the Use of Prednisolone for the Treatment of Mild to Moderate Croup.
dc.typejournal-article
dc.typeCase Reports
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29290883
plymouth.issue1
plymouth.volume11
plymouth.publication-statusPublished
plymouth.journalThe Open Nursing Journal
dc.identifier.doi10.2174/1874434601711010241
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Nursing and Midwifery
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited Arab Emirates
dcterms.dateAccepted2017-11-10
dc.identifier.eissn1874-4346
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.2174/1874434601711010241
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-11-30
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV